Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder HL, Binkin N, Dye C, Williams R, Raviglione MC. Espinal MA, et al. Among authors: kim sj. N Engl J Med. 2001 Apr 26;344(17):1294-303. doi: 10.1056/NEJM200104263441706. N Engl J Med. 2001. PMID: 11320389 Free article.
Determinants of drug-resistant tuberculosis: analysis of 11 countries.
Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE, Smith I, Suarez P, Antunes ML, George AG, Martin-Casabona N, Simelane P, Weyer K, Binkin N, Raviglione MC. Espinal MA, et al. Among authors: kim sj. Int J Tuberc Lung Dis. 2001 Oct;5(10):887-93. Int J Tuberc Lung Dis. 2001. PMID: 11605880
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
Pablos-Méndez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Cohn DL, Lambregts-van Weezenbeek CS, Kim SJ, Chaulet P, Nunn P. Pablos-Méndez A, et al. Among authors: kim sj. N Engl J Med. 1998 Jun 4;338(23):1641-9. doi: 10.1056/NEJM199806043382301. N Engl J Med. 1998. PMID: 9614254 Free article.
Is second-line anti-tuberculosis drug susceptibility testing reliable?
Kim SJ, Espinal MA, Abe C, Bai GH, Boulahbal F, Fattorin L, Gilpin C, Hoffner S, Kam KM, Martin-Casabona N, Rigouts L, Vincent V. Kim SJ, et al. Int J Tuberc Lung Dis. 2004 Sep;8(9):1157-8. Int J Tuberc Lung Dis. 2004. PMID: 15455606 No abstract available.
Measuring tuberculosis burden, trends, and the impact of control programmes.
Dye C, Bassili A, Bierrenbach AL, Broekmans JF, Chadha VK, Glaziou P, Gopi PG, Hosseini M, Kim SJ, Manissero D, Onozaki I, Rieder HL, Scheele S, van Leth F, van der Werf M, Williams BG. Dye C, et al. Among authors: kim sj. Lancet Infect Dis. 2008 Apr;8(4):233-43. doi: 10.1016/S1473-3099(07)70291-8. Epub 2008 Jan 16. Lancet Infect Dis. 2008. PMID: 18201929 Review.
Tuberculosis prevalence surveys: rationale and cost.
Glaziou P, van der Werf MJ, Onozaki I, Dye C, Borgdorff MW, Chiang CY, Cobelens F, Enarson DA, Gopi PG, Holtz TH, Kim SJ, van Leth F, Lew WJ, Lonnroth K, van Maaren P, Narayanan PR, Williams B. Glaziou P, et al. Among authors: kim sj. Int J Tuberc Lung Dis. 2008 Sep;12(9):1003-8. Int J Tuberc Lung Dis. 2008. PMID: 18713496
14,278 results
You have reached the last available page of results. Please see the User Guide for more information.